摘要
1引言
缺血修饰蛋白（Ischemia modified albumin，IMA）是近年来研究较多的一种新的缺血生化标志物。可用于对急性心肌缺血的早期诊断、排除诊断急性冠脉综合征（ACS）及其危险分层。可以降低非缺血患者的收治率和心肌缺血患者的漏诊率，提高医疗资源的利用率。国内对IMA临床研究较少，本研究对其国外临床研究进展作一综述。
出处
《中国现代医药杂志》
2008年第9期120-123,共4页
Modern Medicine Journal of China
参考文献22
-
1[1]Sader PJ,Tucker A,Vilos JH.Involvement of a lysine residue in the N.terminal Ni2+ and Cu2+ binding site of sertlm albumins.Co-mparison with Co2+,Cd2+ and A2+.Eur J Biochem.1994,220:193-200
-
2[2]Bemard Chart.Neil Do&worth Site-specific N-terminal A-Uto-degradation of Human Serum Albumin.European Journal of Biochemistry,1995.227:524-528
-
3[3]David Bar-Or.MDA novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary,report.Journal of Emergency Medicine,2000.19:311-315
-
4[4]MK Sinha D Roy.D C Gaze,et al.RDk of"lschemla Modified Al-bumin".a new biochemical marker of myocardial ischaemia,in the early diagnosis of acute coronary syndromes.Emerg Med J,2004,2l:29-34
-
5[5]Sinha MK.Isehemia medified albumin is a sensitive marker of myocardial isehemia after percutaneous coronary intervention.Circulation,2003,107:2043
-
6[6]Michael C.Kontls.Ischemia reedified albumin:A new bionmrker of myocardial ischemia for early diagnosis of acute coronary syndromes JACC,2003.19:340A
-
7[7]Debashis Boy.Isehemia modified albumin for the assessment of patijents presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiog rams and negative cardiac tropouin T.Intemation Journal of Cardiology,2004.97:297-301
-
8[8]Christenson RH,Duh SH,Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients:a multie\enter study.Clin Chem,2001.47:464-470
-
9[9]Garrido IP.Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angiina pectofis with versus without coronary collaterals.Am J Cardiol,2004,93:88-90
-
10[10]Dusek J.Prognostic significance of ischemia midified albummin after p crcutancous coronary intervention.Clin Chim Acta,2006.367:77-80
同被引文献13
-
1Apple FS,Wu AH,Mair J, et al. Future biomarkers for de- tection of ischemia and risk stratification in acute coronary syndrome[J]. Clin Chem, 2005,51(6) : 810-824.
-
2Worster A, Devereaux PJ, Heels- Ansdell D, et al. Capabili- ty of ischemia modified albumin to predict serious cardiac outcomes in the short term among patients with potential a- cute coronary syndromel-J]. CMAJ, 2005, 172 (13) : 1685- 1690.
-
3Lippi G, Montagnana M, Salvagno GL, et al. Potential valuefor new diagnostic markers in the early recognition of acute coronary syndromes[J]. CJEM, 2006,8 (1) : 27-31.
-
4Abboud H, Labreuche J, Meseguer E, et al. Ischemia- modi- fied albumin in acute stroke[J]. Cerebrovasc Dis, 2007,23 (2-3) : 216-220.
-
5Gunduz A, Turedi S, Mentese A, et al. Ischemia- modified albumin levels in cerebrovaseular accidents [J]. American Journal of Emergency Medicine, 2008,26 (8) : 874-878.
-
6杨明秀,陈红,邱小鹰,陈汉明.急性脑梗死的治疗进展[J].医学综述,2008,14(1):103-105. 被引量：85
-
7李志远,杨曙光.缺血修饰白蛋白临床应用研究进展[J].心血管病学进展,2008,29(5):788-791. 被引量：5
-
8李新春,刘志琴,李小红.缺血修饰白蛋白对急性冠状动脉综合征诊断价值的研究[J].医学综述,2012,18(9):1410-1411. 被引量：12
-
9韩锟,贾宁,闵连秋.脑梗死患者缺血修饰蛋白与血脂水平的相关性研究[J].山东医药,2012,52(32):23-24. 被引量：11
-
10张进,贺长斌(综述),朱勇(校审).脑梗死的影像学诊断与临床治疗进展[J].医学信息,2013(8):692-693. 被引量：1
-
1徐永庆,吴春健.缺血性修饰蛋白和心型脂肪酸结合蛋白在急性心肌梗死早期诊断和严重程度评估中的应用[J].实用医学杂志,2014,30(19):3169-3171. 被引量：14
-
2袁红霞.心肌缺血，缺血修饰蛋白蹿升[J].大众健康,2011(7):53-53.
-
3尚文斌,郭超,王金玲,于希忠,叶丽芳,滕士超.2型糖尿病患者缺血性修饰蛋白的分析[J].中国现代医学杂志,2014,24(35):31-34. 被引量：1
-
4徐永庆,吴春健.心型脂肪酸结合蛋白和缺血性修饰蛋白在急性心肌梗死早期诊断中的应用[J].中国动脉硬化杂志,2014,22(11):1137-1141. 被引量：4
-
5钟长扬,梁丽贞,沈永惠,吴春丽.血清缺血修饰蛋白对急性脑梗死诊断价值的研究[J].中华急诊医学杂志,2014,23(7):816-817. 被引量：9
-
6王宇,薛铮,吕新湖,彭晓恩.缺血性修饰蛋白在诊断急性胸痛中的价值分析[J].岭南心血管病杂志,2017,23(1):45-48. 被引量：5
-
7李海燕.基层医院中糖尿病患者的临床诊治研究[J].基层医学论坛,2015,19(30):4230-4231.
-
8缪国砺.广州地区近年麻疹的临床特点探讨(附87例分析)[J].实用医学杂志,1998,14(12):898-899.
-
9曾展军,薛耀明,沙建平,魏民,卓凤婷,邹艺.糖基化终末产物对人外周血单核细胞分泌单核细胞趋化蛋白-1的影响[J].广东医学,2008,29(11):1778-1779.
-
10王邦琼,张先祥,罗涌.新诊2型糖尿病患者血清缺血修饰蛋白与糖化血红蛋白相关性分析[J].重庆医学,2014,43(6):767-768. 被引量：4
